CanSino Biologics (HKSE:06185) Net Margin % : -148.84% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. CanSino Biologics's Net Income for the three months ended in Mar. 2024 was HK$-184.8 Mil. CanSino Biologics's Revenue for the three months ended in Mar. 2024 was HK$124.1 Mil. Therefore, CanSino Biologics's net margin for the quarter that ended in Mar. 2024 was -148.84%.

The historical rank and industry rank for CanSino Biologics's Net Margin % or its related term are showing as below:

HKSE:06185' s Net Margin % Range Over the Past 10 Years
Min: -12214.46 Med: -429.55 Max: 44.52
Current: -424.99

HKSE:06185's Net Margin % is ranked worse than
92.15% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.43 vs HKSE:06185: -424.99

CanSino Biologics Net Margin % Historical Data

The historical data trend for CanSino Biologics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Net Margin % Chart

CanSino Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-2,138.87

44.52

-88.21

-429.55

CanSino Biologics Quarterly Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial													-138.78	883.24	-92.92	-293.54	-148.84

Competitive Comparison of CanSino Biologics's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanSino Biologics's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's Net Margin % distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's Net Margin % falls into.

CanSino Biologics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CanSino Biologics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1621.781	/	377.553
	=	-429.55 %

CanSino Biologics's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-184.776	/	124.145
	=	-148.84 %

CanSino Biologics (HKSE:06185) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

CanSino Biologics Net Margin % Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics (HKSE:06185) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (HKSE:06185) » Definitions » Net Margin %

Traded in Other Exchanges

CASBF:USA CJH:Germany 688185:China

Address

185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN

Website

https://www.cansinotech.com

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

CanSino Biologics (HKSE:06185) Headlines

No Headlines